Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Xenon Pharmaceuticals Inc shares valued at $91 were sold by GANNON STEVEN on Jun 05 ’25. At $30.48 per share, GANNON STEVEN sold 3 shares. The insider’s holdings dropped to 7,141 shares worth approximately $0.23 million following the completion of this transaction.
Also, MORTIMER IAN sold 22,468 shares, netting a total of over 903,214 in proceeds. Following the sale of shares at $40.20 each, the insider now holds 31,302 shares.
Before that, MORTIMER IAN had sold 16,315 shares from its account. In a trade valued at $660,806, the PRESIDENT & CEO traded Xenon Pharmaceuticals Inc shares for $40.50 each. Upon closing the transaction, the insider’s holdings decreased to 16,315 shares, worth approximately $1.03 million.
As published in their initiating research note from Chardan Capital Markets on May 07, 2025, Xenon Pharmaceuticals Inc [XENE] has been a Buy and the price target has been revised to $55. Analysts at Deutsche Bank started covering the stock with ‘”a Buy”‘ outlook in a report released in mid February. Earlier on October 01, 2024, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for XENE stock.
Analyzing XENE Stock Performance
On last trading session,, Xenon Pharmaceuticals Inc [NASDAQ: XENE] rose 1.67% to $32.80. The stock’s lowest price that day was $31.83, but it reached a high of $33.32 in the same session. During the last five days, there has been a surge of approximately 6.74%. Over the course of the year, Xenon Pharmaceuticals Inc shares have dropped approximately -16.33%.
Support And Resistance Levels for Xenon Pharmaceuticals Inc (XENE)
RSI (Relative Strength Index) is 56.11 on the 14-day chart, showing neutral technical sentiment.
Is Xenon Pharmaceuticals Inc subject to short interest?
Stocks of Xenon Pharmaceuticals Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.22 million shares to 3.37 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 3.58 million shares. A decline of -6.49% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.34 of the overall float, the days-to-cover ratio (short ratio) decline to 2.34.
